Eurofins-Cerep Debt 2024

Eurofins-Cerep Aktienanalyse

What does Eurofins-Cerep do?

Eurofins-Cerep SA is a globally renowned biotechnology company that was founded in 1993. With its headquarters in Paris, France, the company operates over 47 locations worldwide and employs over 45,000 employees. The company specializes in the development and commercialization of innovative biological technologies for use in the pharmaceutical industry. Eurofins-Cerep focuses on the discovery of new drugs for the treatment of diseases such as cancer, Alzheimer's, Parkinson's, and diabetes. The business model of Eurofins-Cerep is based on three pillars: services, product sales, and research and development offerings. Under the "services" division, the company offers extensive pharmacological and biological testing and screening procedures for drug compounds to its customers. Eurofins-Cerep has a wide range of assays and tests that allow customers to assess and optimize the efficacy and safety of their drug compounds. The "product sales" division includes the manufacturing and distribution of over 1,000 different biological reagents, antibodies, and other products for biomedical research. The company specializes in producing reagents used in drug development, such as G-protein coupled receptors (GPCRs). The third pillar of Eurofins-Cerep's business model consists of research and development services for customers and partners. The company supports customers in identifying new drug compounds and developing drug candidates up to market approval. The company has various divisions, including the Cerep division, which specializes in the evaluation of potential drug candidates and associated toxicology. The Eurofins Pharma Discovery Services division offers advanced drug optimization and screening services by providing customized approaches to drug development. The Eurofins BioPharma Services division is a leading provider of complete solutions in the pharmaceutical development and GxP laboratories. The company is also active in other areas such as the environment and the food industry. Eurofins-Cerep has made several acquisitions in the past, including the acquisition of XDS Laboratories, a leading provider of clinical laboratory services, and EAG Laboratories, a highly specialized analysis and testing service unit. Overall, Eurofins-Cerep SA has achieved numerous milestones in the past 28 years and has become one of the world's leading providers of biological screening and analysis technologies. The company remains committed to offering its customers innovative biological technologies and maintaining its reputation as a reliable partner in the pharmaceutical industry. Eurofins-Cerep ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Eurofins-Cerep's Debt Structure

Eurofins-Cerep's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Eurofins-Cerep's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Eurofins-Cerep’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Eurofins-Cerep’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Eurofins-Cerep stock

What is the debt of Eurofins-Cerep this year?

Eurofins-Cerep has a debt level of -12.81 EUR this year.

What was the debt of Eurofins-Cerep compared to the previous year?

The debt of Eurofins-Cerep has increased by 899.07% compared to the previous year increased.

What are the consequences of high debt for investors in Eurofins-Cerep?

High debt can pose a risk for investors of Eurofins-Cerep, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Eurofins-Cerep?

Low debt means that Eurofins-Cerep has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Eurofins-Cerep affect the company?

An increase in debt of Eurofins-Cerep can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Eurofins-Cerep affect the company?

A reduction in debt of Eurofins-Cerep can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Eurofins-Cerep?

Some factors that can influence the debt of Eurofins-Cerep include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Eurofins-Cerep so important for investors?

The debts of Eurofins-Cerep are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Eurofins-Cerep take to change the debt?

To change the debt, Eurofins-Cerep can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Eurofins-Cerep pay?

Over the past 12 months, Eurofins-Cerep paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eurofins-Cerep is expected to pay a dividend of 0 EUR.

What is the dividend yield of Eurofins-Cerep?

The current dividend yield of Eurofins-Cerep is .

When does Eurofins-Cerep pay dividends?

Eurofins-Cerep pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eurofins-Cerep?

Eurofins-Cerep paid dividends every year for the past 0 years.

What is the dividend of Eurofins-Cerep?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eurofins-Cerep located?

Eurofins-Cerep is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurofins-Cerep kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurofins-Cerep from 9/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Eurofins-Cerep pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Eurofins-Cerep in the year 2023?

In the year 2023, Eurofins-Cerep distributed 0 EUR as dividends.

In which currency does Eurofins-Cerep pay out the dividend?

The dividends of Eurofins-Cerep are distributed in EUR.